EPHA2 and metastatic malignant neoplasm in the lymph nodes: EPHA2 mutations have been associated with lymph node metastasis in CCA and targeting the phosphorylation of EPHA2 at Ser897 has shown effectiveness in inhibiting metastasis [116].